Award
Delivery Order #SPE2D326F7570
Pfizer Delivery Order for Dobutamine Injection Under Military Pharmaceutical Contract
Buyer
Defense Logistics Agency
Award Amount
$42.00
Ceiling
$42.00
Awarded
March 09, 2026
Period of Performance
Mar 09, 2026 – Mar 12, 2026
Identifier
SPE2D326F7570
NAICS
325412
This award represents a delivery order contract issued to Pfizer Inc., a leading global pharmaceutical company, to supply Dobutamine 250 mg/20 ml injection vials. The contract falls under a broader indefinite delivery vehicle (IDV) previously awarded to Pfizer to manufacture and distribute essential medical pharmaceuticals critical for military health operations. The delivery order is a short-term, small-scale procurement intended to fulfill specific, timely medical supply requirements within a multi-year framework. It supports the Department of Defense's ongoing efforts to maintain medical readiness by ensuring access to vital injectable medications. The work involves the provision and delivery of Dobutamine vials to a designated location in New York, serving the healthcare needs within military support services. This delivery order is a continuation of Pfizer's trusted role under the competitive IDV contract, affirming its key position as a pharmaceutical supplier to the defense sector. The performance period for this order is a few days in early March 2026, reflecting the contract's focus on prompt fulfillment within the scope of the established IDV arrangement.
Description
4571076500!DOBUTAMINE 250 MG/20 ML VIAL 20ML